Glaxosmithkline | GSK - Capital Ordinário





Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Amgen USD 540M 1000K 2026-03
AstraZeneca USD 1.55B 44K 2026-06
Aurora Cannabis CAD 58.95M 2.24M 2026-03
Bausch Health Companies USD 373.46M 2.93M 2026-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 422.07M 53.78M 2026-03
Corcept Therapeutics USD 107.33M 1.36M 2026-03
Drreddys Laboratories INR 832.69M 123K 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
GlaxoSmithKline GBP 4.08B 20.6M 2026-06
Glaxosmithkline GBP 4.05B 20.6M 2026-03
J&J USD 2.41B 1.35M 2026-03
Merck USD 2.47B 12.72M 2025-12
Novartis USD 1.9B 7.38M 2026-06
Pacira USD 39.31M 1.81M 2026-03
Perrigo USD 138.1M 500K 2026-03
Pfizer USD 5.7B 13M 2026-03
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 47.32M 765K 2025-12
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.21B 8.25M 2026-03
Supernus Pharmaceuticals USD 58.04M 582K 2026-03
Takeda JPY 1.58B 460K 2026-06
Teva Pharmaceutical Industries USD 1.16B 1000K 2026-06
Zoetis USD 420.35M 4.58M 2026-03